TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28235522

Group type: EXPERIMENTAL
Intervention: Ultrasound examination prior to spinal anesthetic placement
Number of subjects: 80

Group type: COMPARATOR
Intervention: Landmark technique only
Number of subjects: 80
Study: 25341548

Group type: EXPERIMENTAL
Intervention: 1% topical sildenafil cream applied to left extremities
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1% topical sildenafil cream applied to right extremities
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1% topical sildenafil cream
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo cream applied to opposite extremity
Number of subjects: 10
Study: 24347531

Group type: EXPERIMENTAL
Intervention: Portable pump
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pole-mounted pump
Number of subjects: 20
Study: 21905270

Group type: EXPERIMENTAL
Intervention: rhGH (Nutropin AQ)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study: 19064988

Group type: EXPERIMENTAL
Intervention: neoadjuvant letrozole
Number of subjects: 114

Group type: COMPARATOR
Intervention: letrozole plus metronomic cyclophosphamide
Number of subjects: 114
Study: 17446014

Group type: EXPERIMENTAL
Intervention: Women's Recovery Group (WRG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed-gender Group Drug Counseling (GDC)
Number of subjects: 0
Study: 15595934

Group type: EXPERIMENTAL
Intervention: levodopa/DDCI/entacapone
Number of subjects: 270

Group type: COMPARATOR
Intervention: levodopa/DDCI/placebo
Number of subjects: 270
Study: 12123209

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 161

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 161
Study: 10192709

Group type: COMPARATOR
Intervention: Clarithromycin 2 g/day and Ethambutol 20 mg/kg/day
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Clarithromycin 2 g/day, Ethambutol 20 mg/kg/day, and Clofazimine 200 mg/day
Number of subjects: 34
Study: 7778534

Group type: EXPERIMENTAL
Intervention: Delapril (7.5 mg twice daily, can be doubled to 30 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril (2.5 mg twice daily, can be doubled to 10 mg twice daily)
Number of subjects: 0
Study: 2271852

Group type: EXPERIMENTAL
Intervention: Antibiotics (20 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No antibiotics (20 patients)
Number of subjects: 40
Study: 6985791

Group type: EXPERIMENTAL
Intervention: Cephalothin sodium
Number of subjects: 400

Group type: COMPARATOR
Intervention: Oxacillin sodium
Number of subjects: 400
Study: 28910673

Group type: EXPERIMENTAL
Intervention: Mindfulness curriculum with parental involvement (N=191)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Mindfulness curriculum without parental involvement (N=186)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Usual curriculum control group (N=178)
Number of subjects: 555
Study: 26160763

Group type: EXPERIMENTAL
Intervention: TachoSil
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control (without TachoSil)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Hand-sewn closure
Number of subjects: 270

Group type: COMPARATOR
Intervention: Mechanical closure
Number of subjects: 270

Group type: COMPARATOR
Intervention: Splenic vessel ligation
Number of subjects: 270

Group type: COMPARATOR
Intervention: Vascular preservation
Number of subjects: 270
Study: 23246646

Group type: EXPERIMENTAL
Intervention: 10 g lactose
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 20 g lactose
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 40 g lactose
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Self-reported lactose intolerance (LI)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dairy product intake
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hydrogen breath tests
Number of subjects: 120
Study: 21990298

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU/d of all rac-α-tocopheryl acetate)
Number of subjects: 35533

Group type: EXPERIMENTAL
Intervention: Selenium (200 μg/d from L-selenomethionine)
Number of subjects: 35533

Group type: EXPERIMENTAL
Intervention: Both selenium and vitamin E
Number of subjects: 35533

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35533
Study: 19858965

Group type: EXPERIMENTAL
Intervention: Facial affect recognition (FAR)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Stories of emotional inference (SEI)
Number of subjects: 19
Study: 17319827

Group type: EXPERIMENTAL
Intervention: Higher platelet dose (HDP)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lower platelet dose (LDP)
Number of subjects: 5
Study: 15067363

Group type: EXPERIMENTAL
Intervention: Germinated barley foodstuff (GBF) 20 g daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Germinated barley foodstuff (GBF) with steroid tapering treatment
Number of subjects: 59
Study: 12127385

Group type: EXPERIMENTAL
Intervention: Fish oil treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (olive oil) treatment
Number of subjects: 27
Study: 9876955

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selegiline and Vitamin E
Number of subjects: 0
Study: 7981584

Group type: EXPERIMENTAL
Intervention: Antibodies to nucleoli in acute EMS patients
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibodies to nucleoli in chronic EMS patients
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibodies to nucleoli in FS patients
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibodies to 5-HT in FS patients
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibodies to 5-HT in acute EMS patients
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibodies to 5-HT in EMS patients after 2 years
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibodies to Gm1 in acute EMS patients
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibodies to Gm1 in chronic EMS patients
Number of subjects: 167

Group type: COMPARATOR
Intervention: Antibodies in healthy controls
Number of subjects: 167
Study: 2547312

Group type: EXPERIMENTAL
Intervention: Glucomannan (1 g tid orally)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 616216

Group type: EXPERIMENTAL
Intervention: Finnish sauna bath without beta-blockade
Number of subjects: 5

Group type: COMPARATOR
Intervention: Finnish sauna bath with beta-blockade (Oxprenolol 40 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exposure to cool swimming pool (22 degrees C) after sauna
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Rest period of 15 min after cool pool
Number of subjects: 5
Study: 31913252

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) 70 ml
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL; black currant juice)
Number of subjects: 11
Study: 31122975

Group type: COMPARATOR
Intervention: High-intensity interval training (HIIT) sessions facilitated by teachers, at least two sessions per week during lesson-time for 3 months, followed by encouragement for sessions outside lesson-time for an additional 6 months.
Number of subjects: 720

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention during the study period).
Number of subjects: 720
Study: 29151559

Group type: EXPERIMENTAL
Intervention: Education about action plans according to self-monitoring program
Number of subjects: 66
Study: 26518207

Group type: EXPERIMENTAL
Intervention: IBWL + ES (internet program plus extra support)
Number of subjects: 100

Group type: COMPARATOR
Intervention: IBWL early non-responders
Number of subjects: 100

Group type: COMPARATOR
Intervention: Early responders (both treatment arms)
Number of subjects: 100
Study: 22744410

Group type: EXPERIMENTAL
Intervention: PerFix™ plug
Number of subjects: 95

Group type: COMPARATOR
Intervention: 4DDOME(®) implant
Number of subjects: 95
Study: 20507399

Group type: EXPERIMENTAL
Intervention: 4-n-butylresorcinol 0.1% cream
Number of subjects: 23

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 23
Study: 18779478

Group type: EXPERIMENTAL
Intervention: Topical ketorolac tromethamine, 0.4%
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 15877875

Group type: EXPERIMENTAL
Intervention: Aleurone flour (ALF) - 175 g bread made with ALF and placebo tablet each day
Number of subjects: 75

Group type: COMPARATOR
Intervention: Folic acid (FA) - 175 g bread made with PCS flour and tablet containing 640 microg folic acid each day
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pericarp seed coat (PCS) - 175 g bread made with PCS flour and placebo tablet each day
Number of subjects: 75
Study: 12931365

Group type: EXPERIMENTAL
Intervention: Sildenafil (50-100 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phentolamine (40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10710012

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (3.5 mg/kg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 11322246

Group type: EXPERIMENTAL
Intervention: 600 mg of saquinavir plus 200 mg of zidovudine
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 200 mg of saquinavir plus 200 mg of zidovudine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Zidovudine monotherapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Other combination therapies (75 mg, 200 mg saquinavir with zidovudine)
Number of subjects: 92
Study: 1934045

Group type: EXPERIMENTAL
Intervention: HBV vaccine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 6138058

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31969687

Group type: EXPERIMENTAL
Intervention: Physiotherapist-led physical activity intervention
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intervention training for physiotherapists
Number of subjects: 300
Study: 31766977

Group type: EXPERIMENTAL
Intervention: Crushed Ticagrelor (CTIC) 180 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Eptifibatide bolus (180 μg/kg×2 intravenous boluses) plus Clopidogrel (600 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Eptifibatide bolus plus Clopidogrel
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Crushed Ticagrelor (CTIC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 28615145

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (n=58)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Normal saline (n=60)
Number of subjects: 118
Study: 25697454

Group type: EXPERIMENTAL
Intervention: 4-week balance training program with external focus instructions
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 4-week balance training program with internal focus instructions
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 4-week balance training program with no focus instructions
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no balance training)
Number of subjects: 49
Study: 24016553

Group type: EXPERIMENTAL
Intervention: Videoconferencing and telephone contact (Intervention Group)
Number of subjects: 1598

Group type: COMPARATOR
Intervention: Standard care (Control Group)
Number of subjects: 1598
Study: 22402329

Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg for four days
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control (uneventful recovery)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control (adverse outcome)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Overall population (270 patients)
Number of subjects: 270
Study: 19680473

Group type: EXPERIMENTAL
Intervention: 10 mg rizatriptan
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17237316

Group type: EXPERIMENTAL
Intervention: Fortified dairy product containing eicosapentaenoic acid, docosahexaenoic acid, oleic acid, folic acid, and vitamins A, B‐6, D, and E (500 mL/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Semi‐skimmed milk with added vitamins A and D (500 mL/d)
Number of subjects: 40
Study: 16784831

Group type: EXPERIMENTAL
Intervention: Granisetron hydrochloride 1mg rapidly disintegrating tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Granisetron hydrochloride 1mg capsules
Number of subjects: 0
Study: 15240527

Group type: EXPERIMENTAL
Intervention: Oral CEE 0.625 mg/day
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Transdermal E2 50 microg/day
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Fenretinide 100 mg/twice a day
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Hormone therapy (both CEE and E2)
Number of subjects: 226
Study: 11074185

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB) as add-on therapy
Number of subjects: 277

Group type: COMPARATOR
Intervention: Phenytoin (PHT) as add-on therapy
Number of subjects: 277

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ) as add-on therapy
Number of subjects: 277
Study: 8990684

Group type: EXPERIMENTAL
Intervention: Minimal Composite Sealant Restoration (MCR)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Glass Ionomer Sealant Restoration (GSR)
Number of subjects: 58
Study: 1424620

Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptive (ethinyl estradiol and gestodene)
Number of subjects: 1933
Study: 3883735

Group type: EXPERIMENTAL
Intervention: Molsidomine
Number of subjects: 12
Study: 31005588

Group type: EXPERIMENTAL
Intervention: VR mApp
Number of subjects: 105

Group type: COMPARATOR
Intervention: mApp
Number of subjects: 105
Study: 28165546

Group type: EXPERIMENTAL
Intervention: Standard management (SM) associated with oral daily supplementation of 120 mg cranberry extract (Anthocran®), standardized to 36 mg proanthocyanidins for 60 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Before inclusion (baseline)
Number of subjects: 36
Study: 25584474

Group type: EXPERIMENTAL
Intervention: Active observation with checklist
Number of subjects: 232

Group type: COMPARATOR
Intervention: Passive observation
Number of subjects: 232
Study: 23695976

Group type: EXPERIMENTAL
Intervention: BrAC estimation training
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 46
Study: 20530107

Group type: EXPERIMENTAL
Intervention: Ventilator-delivered mask ventilation (VDMV)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Laerdal self-inflating bag (SIB)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Anaesthetic bag and T-piece Neopuff
Number of subjects: 36
Study: 19517672

Group type: EXPERIMENTAL
Intervention: Intravenous piracetam 30 mg kg(‐1)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 17090953

Group type: EXPERIMENTAL
Intervention: L-thyroxine (L-T4) administration after 2 months of therapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: L-thyroxine (L-T4) administration
Number of subjects: 24

Group type: COMPARATOR
Intervention: No L-thyroxine (L-T4) treatment
Number of subjects: 24
Study: 15310558

Group type: EXPERIMENTAL
Intervention: Monoamine oxidase type B inhibitors (MAOBIs)
Number of subjects: 3525

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 3525
Study: 11783838

Group type: EXPERIMENTAL
Intervention: Standard discectomy for proven disc herniation (<= 1 year)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local triamcinolone injection for lateral epicondylitis (<= 12 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative steroid at discectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural steroid injection for sciatica with low back pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caudal steroid injection for low back pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local glycosaminoglycan polyphosphate injection for lateral epicondylitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraarticular steroid injection for shoulder arthritis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subacromial steroid injections for rotator cuff tendinitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonspecific injections for painful shoulder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic growth hormone for fibromyalgia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous adenosine for fibromyalgia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with steroid and local anesthetic
Number of subjects: 0
Study: 9395805

Group type: EXPERIMENTAL
Intervention: TRAb positivity in Graves' disease (GD) patients
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: TRAb positivity in chronic lymphocytic thyroiditis (CLT) patients
Number of subjects: 265

Group type: COMPARATOR
Intervention: TRAb positivity in other thyroid disorders
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Sensitivity of TRAb compared to anti-thyroglobulin antibodies
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Sensitivity of TRAb compared to anti-microsomal antibodies
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Specificity of TRAb levels > 10.0 U/L
Number of subjects: 265
Study: 7957520

Group type: EXPERIMENTAL
Intervention: Transdermal dexmedetomidine (625 micrograms applied for 12 h)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine (2.0 micrograms.kg‐1 as dexmedetomidine hydrochloride administered as an infusion over 5 min)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Transdermal dexmedetomidine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine
Number of subjects: 9
Study: 3122595

Group type: EXPERIMENTAL
Intervention: Propofol/fentanyl/nitrous oxide anaesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Antagonised midazolam anaesthesia (midazolam/fentanyl/isoflurane/nitrous oxide with flumazenil 1 mg)
Number of subjects: 100
Study: 31230088

Group type: EXPERIMENTAL
Intervention: 18F‐DCFPyL PET/CT
Number of subjects: 248
Study: 28554939

Group type: EXPERIMENTAL
Intervention: Simplified clinical algorithm for ART initiation (SLATE)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Standard arm (routine, standard of care ART initiation)
Number of subjects: 960
Study: 24620734

Group type: EXPERIMENTAL
Intervention: Training for exercise during pregnancy
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Training for exercise during pregnancy and post-partum period until 2 months after delivery
Number of subjects: 127

Group type: COMPARATOR
Intervention: No intervention group
Number of subjects: 127
Study: 23723457

Group type: EXPERIMENTAL
Intervention: Double dose oseltamivir (150 mg twice a day)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Standard dose oseltamivir (75 mg twice a day)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Double dose oseltamivir
Number of subjects: 326

Group type: COMPARATOR
Intervention: Standard dose oseltamivir
Number of subjects: 326
Study: 21986780

Group type: EXPERIMENTAL
Intervention: Methylsulfonylmethane (5 g daily) and boswellic acids (7.2 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19485978

Group type: EXPERIMENTAL
Intervention: pegylated‐interferon‐alpha2a (180 microg once weekly) plus ribavirin (1000‐1200 mg/daily) with amantadine (200 mg/daily)
Number of subjects: 630

Group type: COMPARATOR
Intervention: pegylated‐interferon‐alpha2a (180 microg once weekly) plus ribavirin (1000‐1200 mg/daily) without amantadine
Number of subjects: 630
Study: 17018656

Group type: EXPERIMENTAL
Intervention: Magnesium (300 mg elemental Mg per day in two divided doses)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 15339258

Group type: COMPARATOR
Intervention: Auditory (AD) stimulation alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vibrotactile (VT) + Auditory (AD) stimulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined VT + AD stimulation
Number of subjects: 10
Study: 14641355

Group type: EXPERIMENTAL
Intervention: Bepanthol Handbalsam containing 5% dexpanthenol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11166015

Group type: EXPERIMENTAL
Intervention: Standard dietary treatment (50% to 55% carbohydrate and 30% fat for 2 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No diet applied (control group)
Number of subjects: 30
Study: 8848058

Group type: EXPERIMENTAL
Intervention: 2-day preparatory programme (medical information, relaxation exercises, group discussions)
Number of subjects: 223

Group type: COMPARATOR
Intervention: 2-hour information programme
Number of subjects: 223
Study: 1538094

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Physiologic saline solution
Number of subjects: 120
Study: 6397849

Group type: EXPERIMENTAL
Intervention: 50 mg doxepin for 4 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 30919997

Group type: EXPERIMENTAL
Intervention: Denosumab treatment for up to 10 years
Number of subjects: 1343
Study: 30550334

Group type: EXPERIMENTAL
Intervention: Video presentation intervention (VPI) - role models descending the same staircase
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Video presentation intervention (VPI) - role models descending an unfamiliar staircase
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group - irrelevant control video
Number of subjects: 90
Study: 27176871

Group type: EXPERIMENTAL
Intervention: Robotic follicular unit graft selection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Random follicular unit harvesting (control)
Number of subjects: 24
Study: 24691680

Group type: EXPERIMENTAL
Intervention: Self-compassion intervention (n = 27)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Active control group (n = 25)
Number of subjects: 52
Study: 22980301

Group type: EXPERIMENTAL
Intervention: Intravenous high dose of furosemide with hypertonic saline solution (HSS)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Intravenous high dose of furosemide without hypertonic saline solution (Control group)
Number of subjects: 248
Study: 20591795

Group type: EXPERIMENTAL
Intervention: Tailored telephone reminder call by community peer volunteers
Number of subjects: 3880

Group type: COMPARATOR
Intervention: Usual care (control) arm
Number of subjects: 3880